clinical trial · NCT07531043
Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adults
Alcon Research·phase3·not yet recruiting·n = 230
Ocular HyperemiaApraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative FreeVehicle
brief summary
The purpose of this study is to evaluate the efficacy and safety of an investigational ophthalmic solution in adults with ocular redness due to minor eye irritations.
started
Oct 1, 2026
primary completion
Feb 1, 2027
completion
Feb 1, 2027
last updated
Jun 10, 2026
detailed description
Eligible subjects will be expected to attend a total of 3 in-office study visits over a period of approximately 1 week. Subjects will receive a single dose of the study treatment in each eye on Day 1 (Visit 2). Eye redness will be assessed before and after instillations at prespecified timepoints.
official title
A Two-Arm Multicenter Clinical Trial to Investigate Efficacy and Safety of FID123472 Ophthalmic Solution Compared With Vehicle in Adult Subjects With Ocular Redness
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol